最新技术审查:化物利尿剂通过NAPE-PLD利用内分泌系统
1Laboratori ALIVEDA, Viale Karol Wojtyla 19, 56042 Crespina Lorenzana, Pisa, Italy.
American journal of hypertension
|September 2, 2025
概括
针对内分泌系统 (ECS) 提供新的高血压治疗方法. 酸性利尿剂不知不觉地通过NAPE-PLD向ECS,提供一种经过验证的血管疾病管理方法.
科学领域:
- 药理学
- 内分泌学
- 心血管医学
背景情况:
- 已经探索了内分泌系统 (ECS) 管理高血压和血管疾病.
- 之前针对大麻素受体1 (CB1) 和CB2激动剂以及CB1抑制剂的尝试因不良副作用而面临挑战.
- 脂肪酸胺酶 (FAAH) 抑制剂在高血压大鼠的血压正常化方面显示出有前途.
研究的目的:
- 审查针对高血压和血管疾病的ECS技术的现状.
- 阐明 thiazide 利尿剂的机制及其与 ECS 的联系.
- 验证一种用于治疗高血压和血管抵抗的新方法.
主要方法:
- 对心血管疾病ECS调节的现有文献的审查.
- 对脂酶NAPE-PLD作为 thiazide 利尿剂的标作用的研究.
- 通过NAPE-PLD影响利尿作用和胺生成的机制的分析.
主要成果:
- 酸性利尿剂向与ECS相关的酶NAPE-PLD,这显示出对ECS调节的长期临床方法.
- NAPE-PLD的激活促进了利尿作用,并产生了胺,为慢性高血压治疗提供了保护作用.
- 通过其 thiazide 结合部位稳定 NAPE- PLD 有效治疗高血压和血管抵抗.
结论:
- 医生无意中通过酸性利尿剂准了ECS超过60年.
- 在高血压和相关的血管疾病中,NAPE-PLD是经过验证的ECS调节的系统标.
- 稳定NAPE-PLD的化学药物为与高血压相关的神经血管变化提供了有前途的治疗策略.
相关概念视频
Antihypertensive Drugs: Thiazide-Class Diuretics
2.3K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
2.3K
Antihypertensive Drugs: Potassium-Sparing Diuretics
2.6K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.5K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.5K
Opioid Receptors: Overview
7.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.2K
Analgesia and Pain Management
3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K


